ZIRMANA Trademark

Trademark Overview


On Tuesday, April 11, 2017, a trademark application was filed for ZIRMANA with the United States Patent and Trademark Office. The USPTO has given the ZIRMANA trademark a serial number of 87406397. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 29, 2020. This trademark is owned by Intarcia Therapeutics, Inc.. The ZIRMANA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders; an implantable subdermal drug delivery device filled with a pharmaceutical preparation for the treatment of diabetes, obesity and metabolic diseases/disorders; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders

Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders
zirmana

General Information


Serial Number87406397
Word MarkZIRMANA
Filing DateTuesday, April 11, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 29, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders; an implantable subdermal drug delivery device filled with a pharmaceutical preparation for the treatment of diabetes, obesity and metabolic diseases/disorders; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders
Goods and ServicesDrug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, April 18, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntarcia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameIntarcia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Monday, June 29, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 29, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 24, 2019EXTENSION 4 GRANTED
Sunday, November 24, 2019EXTENSION 4 FILED
Sunday, November 24, 2019TEAS EXTENSION RECEIVED
Saturday, May 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2019EXTENSION 3 GRANTED
Thursday, May 23, 2019EXTENSION 3 FILED
Thursday, May 23, 2019TEAS EXTENSION RECEIVED
Wednesday, September 5, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 5, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2018EXTENSION 2 GRANTED
Wednesday, July 18, 2018EXTENSION 2 FILED
Wednesday, July 18, 2018TEAS EXTENSION RECEIVED
Saturday, May 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 1 GRANTED
Thursday, May 24, 2018EXTENSION 1 FILED
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, October 15, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, September 22, 2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, September 22, 2017ASSIGNED TO PETITION STAFF
Friday, September 1, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, July 5, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2017ASSIGNED TO EXAMINER
Tuesday, April 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 14, 2017NEW APPLICATION ENTERED IN TRAM